Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
- Resource Type
- Article
- Source
- In
The Lancet 1-7 August 2015 386(9992):452-460 - Subject
Primary Research Articles - Language
- ISSN
- 0140-6736